Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cohance Lifesciences: A Global CDMO Platform with Multi-Modality Expertise | Contract Pharma
Sponsored Videos

Cohance Lifesciences: A Global CDMO Platform with Multi-Modality Expertise

Small Molecules. ADCs. Nucleic Acid Chemistry.

Released By Cohance Lifesciences

Cohance Lifesciences is a global CDMO platform helping pharmaceutical innovators solve complex development and manufacturing challenges across Small Molecules, Antibody Drug Conjugates (ADCs), and Nucleic Acid Chemistry. Backed by more than 35 years of scientific expertise, an integrated network of manufacturing and R&D facilities across India and the United States, and trusted partnerships with the leading pharmaceutical innovators, Cohance supports customers from process development and scale-up through commercial manufacturing.

In this CDMO overview video, discover how Cohance combines advanced small molecule chemistry expertise, ADC leadership through NJ Bio, specialized nucleic acid chemistry capabilities through Sapala Organics, and robust manufacturing infrastructure to help accelerate the development of next-generation therapies.

Key Highlights:

  • Global CDMO platform with expertise across Small Molecules, ADCs, and Nucleic Acid Chemistry
  • 35+ years of scientific and manufacturing excellence
  • Integrated development, scale-up, and commercial manufacturing capabilities
  • Advanced chemistry expertise including HPAPIs, flow chemistry, and complex conjugate chemistry
  • ADC capabilities spanning Discovery and IND-enabling chemistry, payload-linkers and bioconjugation
  • Specialized nucleic acid chemistry capabilities including amidites, modified nucleosides, GalNAc conjugates, and oligonucleotide building blocks
  • Strategic operations across India and the United States

Collaborate. Enhance. Deliver.

Learn more at www.cohance.com

Click here to meet with Cohance at CPHI Milan

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Request more information from Cohance Lifesciences